Balyasny Asset Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Sell |
-2,598
| Closed | -$111K | – | 1831 |
|
2018
Q2 | $111K | Buy |
2,598
+1,487
| +134% | +$63.5K | ﹤0.01% | 1525 |
|
2018
Q1 | $73K | Buy |
+1,111
| New | +$73K | ﹤0.01% | 1660 |
|
2017
Q2 | – | Sell |
-22,137
| Closed | -$4.8M | – | 1559 |
|
2017
Q1 | $4.8M | Buy |
+22,137
| New | +$4.8M | 0.02% | 603 |
|
2016
Q4 | – | Sell |
-8,728
| Closed | -$1.18M | – | 1313 |
|
2016
Q3 | $1.18M | Buy |
8,728
+395
| +5% | +$53.4K | 0.01% | 656 |
|
2016
Q2 | $845K | Buy |
+8,333
| New | +$845K | 0.01% | 593 |
|
2014
Q2 | – | Sell |
-3,333
| Closed | -$852K | – | 611 |
|
2014
Q1 | $852K | Buy |
+3,333
| New | +$852K | 0.01% | 384 |
|